Press Releases from DelveInsight Business Research LLP (2368 total)
Osteoarthritis Pipeline Outlook Report 2024 | Biosplice Therapeutics, Gilead Sci …
DelveInsight's, "Osteoarthritis Pipeline Insight 2024" report provides comprehensive insights about 130+ companies and 130+ pipeline drugs in the Osteoarthritis pipeline landscape. It covers the Osteoarthritis pipeline drug profiles, including Osteoarthritis clinical trials and nonclinical stage products. It also covers the Osteoarthritis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Osteoarthritis Pipeline…
Ocular Hypertension Pipeline Outlook Report 2024 | Nicox, Qlaris Bio, TheratOcul …
DelveInsight's, "Ocular Hypertension Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ocular Hypertension pipeline landscape. It covers the Ocular Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ocular Hypertension pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Obesity Pipeline Outlook Report 2024 | Aardvark Therapeutics, Adocia, Agentix, A …
DelveInsight's, "Obesity Pipeline Insight 2024" report provides comprehensive insights about 100+ Obesity companies and 130+ Obesity pipeline drugs in the Obesity pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Obesity therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Obesity pipeline products in this space.
Key Takeaways from the Obesity Pipeline Report
• DelveInsight's Obesity…
Non Alcoholic Fatty Liver Disease Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Non-Alcoholic Fatty Liver Disease Pipeline Insight 2023" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Non-Alcoholic…
NK Cell Therapy Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "NK Cell Therapy Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 185+ pipeline drugs in NK Cell Therapy pipeline landscape. It covers the NK Cell Therapy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the NK Cell Therapy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
Myelodysplastic Syndrome Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the Myelodysplastic Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelodysplastic Syndrome pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Myelodysplastic…
Multiple Sclerosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Multiple Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape. It covers the Multiple Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple Sclerosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Multiple Myeloma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Multiple Myeloma Pipeline Insights 2024" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape. It covers the Multiple Myeloma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple Myeloma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from…
Metastatic Melanoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Melanoma Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Melanoma pipeline landscape. It covers the Metastatic Melanoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Melanoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Metastatic Colorectal Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Colorectal Cancer Pipeline Insight 2024" report provides comprehensive insights about 130+ companies and 140+ pipeline drugs in the Metastatic Colorectal Cancer pipeline landscape. It covers the Metastatic Colorectal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Colorectal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Metastatic Castration-Resistant Prostate cancer Pipeline Outlook Report 2024 (Up …
DelveInsight's, "Metastatic Castration-Resistant Prostate Cancer Pipeline Insight 2023" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Castration-Resistant Prostate Cancer pipeline landscape. It covers the Metastatic Castration-Resistant Prostate Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Castration-Resistant Prostate Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline…
Metastatic Breast Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Metastatic Breast Cancer pipeline landscape. It covers the Metastatic Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Major Depressive Disorder Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Major Depressive Disorder Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Major Depressive Disorder pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Liver Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Liver Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape. It covers the Liver Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Liver Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Liver…
Influenza Pipeline Outlook, Clinical Trials, and Emerging Therapies Report 2024
The Influenza Pipeline Insight 2024 report by DelveInsight offers a thorough global overview of Influenza treatments, including those already in the market, as well as those in different phases of clinical development. Prominent pharmaceutical firms are dedicated to progressing the pipeline landscape and fostering the potential growth of Influenza therapeutic advancements.
Key Takeaways from the Influenza Pipeline Report
• DelveInsight's Influenza pipeline report depicts a robust space with 120+ active players working…
Idiopathic Pulmonary Fibrosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Idiopathic Pulmonary Fibrosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Hypertension Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hypertension Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hypertension pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hypertension Pipeline Report
• DelveInsight's Hypertension…
HER2-Negative Breast Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "HER2-Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the HER2-Negative Breast Cancer pipeline landscape. It covers the HER2-Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the HER2-Negative Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Hepatocellular Carcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hepatocellular…
Hepatitis B Virus Infection Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hepatitis B Virus Infection Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Hepatitis B Virus Infection pipeline landscape. It covers the Hepatitis B Virus Infection pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatitis B Virus Infection pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products…
Hemophilia Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hemophilia Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hemophilia Pipeline Report
• DelveInsight's Hemophilia pipeline…
Head and Neck Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Head and Neck Cancer Pipeline Insight, 2024," report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Head and Neck cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Head and Neck…
DDR Defective Tumors Market Report 2032 | DelveInsight
DelveInsight's "DDR Defective Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DDR Defective Tumors, historical and forecasted epidemiology as well as the DDR Defective Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The DDR Defective Tumors market report provides current treatment practices, emerging drugs, DDR Defective Tumors market share of the individual therapies, and current…
Invasive Pneumococcal Disease Market to Show a Rise, asserts DelveInsight | Phar …
DelveInsight's "Invasive Pneumococcal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Invasive Pneumococcal Disease, historical and forecasted epidemiology as well as the Invasive Pneumococcal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Invasive Pneumococcal Disease market report provides current treatment practices, emerging drugs, Invasive Pneumococcal Disease market share of the individual therapies, and current…
Primary Myelofibrosis Market to Show a Rise, asserts DelveInsight | Pharma giant …
DelveInsight's "Primary Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Primary Myelofibrosis, historical and forecasted epidemiology as well as the Primary Myelofibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Primary Myelofibrosis market report provides current treatment practices, emerging drugs, Primary Myelofibrosis market share of the individual therapies, and current and forecasted Primary Myelofibrosis market…
Positive Air Pressure Device Market Insights by DelveInsight | Prominent pharmac …
"DelveInsight's 'Positive Air Pressure Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Positive Air Pressure Devices and the historical and forecasted Positive Air Pressure Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Request for a sample copy of the Positive Air Pressure Device Market report @ https://www.delveinsight.com/sample-request/positive-air-pressure-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
The Positive Air Pressure Device market report offers an overview of the Positive…
Ladarixin Market Size expected to increase many folds by 2032, reports DelveInsi …
[Las Vegas, United States] (21th March 2024) The Latest report, LADARIXIN Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the LADARIXIN market landscape and market forecast of LADARIXIN up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of LADARIXIN in 2032? Click @ LADARIXIN Market Size-…
TRESIBA Market Size expected to increase many folds by 2032, reports DelveInsigh …
[Las Vegas, United States] (21th March 2024) The Latest report, TRESIBA Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the TRESIBA market landscape and market forecast of TRESIBA up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of TRESIBA in 2032? Click @ TRESIBA Market Size-…
TOUJEO Market Size expected to increase many folds by 2032, reports DelveInsight
[Las Vegas, United States] (21th March 2024) The Latest report, TOUJEO Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the TOUJEO market landscape and market forecast of TOUJEO up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of TOUJEO in 2032? Click @ TOUJEO Market Size-…
AFREZZA Market Size expected to increase many folds by 2032, reports DelveInsigh …
[Las Vegas, United States] (4th March 2024) The Latest report, AFREZZA Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the AFREZZA market landscape and market forecast of AFREZZA up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of AFREZZA in 2032? Click @ AFREZZA Market Size-…
FIASP Market Size expected to increase many folds by 2032, reports DelveInsight
[Las Vegas, United States] (4th March 2024) The Latest report, FIASP Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the FIASP market landscape and market forecast of FIASP up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of FIASP in 2032? Click @ FIASP Market Size-…
Exosomes Pipeline Outlook Report 2024 | Capricor Therapeutics, Direct Biologics, …
DelveInsight's, "Exosomes Pipeline Insight 2024" report provides comprehensive insights about 60+ companies and 110+ pipeline drugs in the Exosomes pipeline landscape. It covers the Exosomes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Exosomes pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Exosomes Pipeline Report
• DelveInsight's Exosomes…
Esophageal Cancer Pipeline Outlook Report 2024 | BeiGene, AstraZeneca, CSPC Zhon …
DelveInsight's, "Esophageal Cancer Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Esophageal Cancer pipeline landscape. It covers the Esophageal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Esophageal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Eczema Pipeline Outlook Report 2024 | LEO Pharma, GlaxoSmithKline, Arjil Pharmac …
DelveInsight's, "Eczema Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers the Eczema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Eczema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Eczema Pipeline Report
• DelveInsight's Eczema pipeline…
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Dry Age-Related Macular Degeneration Pipeline Outlook Report 2024
DelveInsight's, "Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024" report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration (Dry-AMD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Gallbladder Cancer Market to Show Incremental Growth, estimates DelveInsight | P …
DelveInsight's "Gallbladder Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gallbladder Cancer, historical and forecasted epidemiology as well as the Gallbladder Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Gallbladder Cancer market report provides current treatment practices, emerging drugs, Gallbladder Cancer market share of the individual therapies, current and forecasted Gallbladder Cancer market Size from…
LAG-3-Next Generation Immunotherapy Market to Showcase Robust Growth in the Upco …
DelveInsight's "Lymphocyte Activation Gene-3 (LAG-3) Competitive Landscape and Market Forecast - 2035" report delivers an in-depth understanding of the LAG-3, historical and forecasted market trends of LAG-3 in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The report covers a descriptive overview including history, mechanism, principles, categories, advantages/ limitations of LAG-3 Next-generation Immunotherapies, and currently available therapies from 2019 to 2035 segmented by seven major markets.…
Renal Anemia Market to Show Incremental Growth During the Forecast Period | Prom …
DelveInsight's "Renal Anemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Renal Anemia, historical and forecasted epidemiology as well as the Renal Anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Renal Anemia market report provides current treatment practices, emerging drugs, Renal Anemia market share of the individual therapies, current and forecasted Renal Anemia market Size…
Tinnitus Market to Show Incremental Growth | Prominent players: Mallinckrodt plc …
DelveInsight's "Tinnitus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Tinnitus, historical and forecasted epidemiology as well as the Tinnitus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Tinnitus market report provides current treatment practices, emerging drugs, Tinnitus market share of the individual therapies, current and forecasted Tinnitus market Size from 2019 to 2032 segmented by…
Trauma Fixation Devices Market to Showcase Robust Growth in the Upcoming Years | …
The global market for trauma fixation devices was valued at USD 7.03 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.42% from 2023 to 2028, reaching USD 10.21 billion by 2028. Driving factors include the increasing demand for advanced technological solutions, a growing elderly population, higher occurrences of accidents and trauma, escalating prevalence of degenerative bone ailments, and an upsurge in sports-related…
Pyoderma Gangrenosum Market to Show Incremental Growth, estimates DelveInsight | …
DelveInsight's "Pyoderma Gangrenosum Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pyoderma Gangrenosum, historical and forecasted epidemiology as well as the Pyoderma Gangrenosum market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Pyoderma Gangrenosum market report provides current treatment practices, emerging drugs, Pyoderma Gangrenosum market share of the individual therapies, and current and forecasted Pyoderma Gangrenosum market…
Myocarditis Market to Show Incremental Growth, estimates DelveInsight | Prominen …
DelveInsight's "Myocarditis Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Myocarditis, historical and forecasted epidemiology as well as the Myocarditis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Myocarditis market report provides current treatment practices, emerging drugs, Myocarditis market share of the individual therapies, current and forecasted Myocarditis market Size from 2017 to 2030 segmented by seven…
Erythromelalgia Market to Show Incremental Growth | Prominent players: Regeneron …
DelveInsight's "Erythromelalgia- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Erythromelalgia, historical and forecasted epidemiology as well as the Erythromelalgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Erythromelalgia market report provides current treatment practices, emerging drugs, Erythromelalgia market share of the individual therapies, current and forecasted Erythromelalgia market Size from 2019 to 2032 segmented by…
Lassa Fever Market to Show Incremental Growth, estimates DelveInsight | Prominen …
DelveInsight's "LassaFever- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lassa Fever, historical and forecasted epidemiology as well as the Lassa Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Lassa Fever market report provides current treatment practices, emerging drugs, Lassa Fever market share of the individual therapies, current and forecasted Lassa Fever market Size from…
COVID-19 Pipeline Outlook Report 2024 | Uni-Pharma Kleon Tsetis Pharmaceutical L …
DelveInsight's, "COVID-19 Pipeline Insight 2024" report provides comprehensive insights about 400+ companies and 400+ pipeline drugs in the COVID-19 pipeline landscape. It covers the COVID-19 pipeline drug profiles, including clinical and nonclinical stage products. It also covers the COVID-19 therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the COVID-19 Pipeline Report
• DelveInsight's COVID-19 pipeline…
Crohn's Disease Pipeline Outlook Report 2024 | Janssen, RedHill Biopharma, Amgen …
DelveInsight's, "Crohn's Disease Pipeline Insight, 2024" report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn's Disease pipeline landscape. It covers the Crohn's Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Crohn's Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Crohn's…
Cystic Fibrosis Pipeline Outlook Report 2024 | Krystal Biotech, Vertex Pharmaceu …
DelveInsight's, "Cystic Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Cystic Fibrosis pipeline landscape. It covers the Cystic Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cystic Fibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Cystic…
Chronic Kidney Disease Pipeline Outlook Report 2024 | Boehringer Ingelheim, Eli …
DelveInsight's, "Chronic Kidney Disease Pipeline Insights 2024" report provides comprehensive insights about 76+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape. It covers the Chronic Kidney Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Kidney Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Breast Cancer Pipeline, FDA Approvals, Clinical Trials Developments, and Compani …
DelveInsight's, "Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 120+ Breast Cancer companies and 130+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
